Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Argus Health
AstraZeneca
Moodys
Fuji
Novartis
Cantor Fitzgerald
Boehringer Ingelheim
Farmers Insurance
Healthtrust

Generated: February 19, 2018

DrugPatentWatch Database Preview

Allergan Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ALLERGAN INC, and what generic alternatives to ALLERGAN INC drugs are available?

ALLERGAN INC has two approved drugs.

There are five US patents protecting ALLERGAN INC drugs on ALLERGAN INC drugs in the past three years.

There are twenty-two patent family members on ALLERGAN INC drugs in fifteen countries.

Summary for Allergan Inc
International Patents:22
US Patents:5
Tradenames:2
Ingredients:2
NDAs:2
Drug Master File Entries: 4

Drugs and US Patents for Allergan Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan Inc RHOFADE oxymetazoline hydrochloride CREAM;TOPICAL 208552-001 Jan 18, 2017 RX Yes Yes 8,883,838 ➤ Sign Up Y ➤ Sign Up
Allergan Inc RHOFADE oxymetazoline hydrochloride CREAM;TOPICAL 208552-001 Jan 18, 2017 RX Yes Yes 8,420,688 ➤ Sign Up ➤ Sign Up
Allergan Inc ACZONE dapsone GEL;TOPICAL 207154-001 Feb 24, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up
Allergan Inc RHOFADE oxymetazoline hydrochloride CREAM;TOPICAL 208552-001 Jan 18, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up
Allergan Inc ACZONE dapsone GEL;TOPICAL 207154-001 Feb 24, 2016 RX Yes Yes 9,517,219 ➤ Sign Up ➤ Sign Up
Allergan Inc ACZONE dapsone GEL;TOPICAL 207154-001 Feb 24, 2016 RX Yes Yes 9,161,926 ➤ Sign Up Y ➤ Sign Up
Allergan Inc RHOFADE oxymetazoline hydrochloride CREAM;TOPICAL 208552-001 Jan 18, 2017 RX Yes Yes 7,812,049 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Allergan Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan Inc ACZONE dapsone GEL;TOPICAL 207154-001 Feb 24, 2016 5,863,560 ➤ Sign Up
Allergan Inc ACZONE dapsone GEL;TOPICAL 207154-001 Feb 24, 2016 6,060,085 ➤ Sign Up
Allergan Inc ACZONE dapsone GEL;TOPICAL 207154-001 Feb 24, 2016 6,620,435 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ALLERGAN INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Gel 7.5% ➤ Subscribe 2/13/2017

Non-Orange Book US Patents for Allergan Inc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
2,017,231,985 ➤ Sign Up
8,815,929 Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using .alpha..sub.1-adrenoceptor agonists ➤ Sign Up
8,877,793 Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using .alpha..sub.1-adrenoceptor agonists ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Allergan Inc Drugs

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Queensland Health
AstraZeneca
UBS
Chubb
Dow
Covington
Federal Trade Commission
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot